Back to Treatments

Treatment

Finasteride (5-alpha-reductase inhibitor)

1
Conditions
13
Trials
30K
Participants
62%
Average Safety

Condition Evidence

Benign Prostatic Hyperplasia

13 trials · 30K participants

55% effectiveness · 62% safety
Finasteride (5-alpha-reductase inhibitor) | DFDA